Antibodies specifically directed to a soluble form of CTLA-4

Frank James Ward (Inventor), Robert Norman Barker (Inventor), Lekh Nath Dahal (Inventor)

Research output: Patent

29 Downloads (Pure)

Abstract

The invention provides materials and methods relating to antibodies specific for a soluble form of CTLA-4 (sCLTA-4). Such antibodies have been shown to have a strong boosting effect on antigen-specific human immune responses.
Original languageEnglish
Patent numberUS8697845 B2
Priority date15/04/14
Publication statusPublished - 2 Sep 2010

    Fingerprint

Cite this

Ward, F. J., Barker, R. N., & Dahal, L. N. (2010). Antibodies specifically directed to a soluble form of CTLA-4. (Patent No. US8697845 B2).